McMaster University’s Dr Derek Chu, fellow in clinical immunology and allergy, and Dr David McCullagh, fellow in infectious disease, advise on how to best approach a patient with penicillin allergy as a family physician.
McMaster University’s Dr David McCullagh, fellow in infectious disease, and Dr Derek Chu, fellow in clinical immunology and allergy, discuss approaches to patients at risk of penicillin allergy in the acute setting.
Dr Bram Rochwerg, critical care expert and member of the Society of Critical Care Medicine and European Society of Intensive Care Medicine Corticosteroid Guideline Task Force, explains the rationale and evidence behind using steroids in pneumonia and ARDS.
Dr Bram Rochwerg, critical care expert and member of the Society of Critical Care Medicine and European Society of Intensive Care Medicine Corticosteroid Guideline Task Force, discusses updated recommendations on use of steroids in sepsis.
Dr Yaseen Arabi, chairman of Intensive Care Department at King Abdulaziz Medical City and professor at King Saud bin Abdulaziz University for Health Sciences, explains in detail the surprising findings from his group’s study on mechanical VTE prophylaxis in critical care.
Dr Yaseen Arabi, chairman of the Intensive Care Department at King Abdulaziz Medical City and professor at King Saud bin Abdulaziz University for Health Sciences, explains the recently published results from a study on pneumatic compression devices in critical care.
Dr Gordon Guyatt, distinguished professor in the department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses reasons behind using aspirin in primary prevention in light of recent studies.
Dr Derek Chu, resident in the Clinical Immunology and Allergy Program at McMaster University and recipient of the 2009 Vanier award from the Canadian Institutes of Health Research (CIHR), discusses implications of the recent IOTA study.
Dr Derek Chu, resident in the Clinical Immunology and Allergy Program at McMaster University and recipient of the 2009 Vanier award from the Canadian Institutes of Health Research (CIHR), discusses implications of the recent IOTA study.
Dr Gordon Guyatt, distinguished professor at McMaster University and one of the founders of EBM, discusses characteristics of a trustworthy guideline.
English
Polski
Español
українська